Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W I Bensinger

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|September 1, 1996
Syngeneic marrow transplantation in patients with multiple myelomaW I Bensinger, T Demirer, C D Buckner, et al.
Leukemia|March 2, 2012
Evaluating surface erythropoietin receptor in multiple myelomaC P Miller, K Rattray, Y Zhang, et al.
Bone Marrow Transplantation|November 1, 1994
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignanciesC H Weaver, W I Bensinger, F R Appelbaum, et al.
Bone Marrow Transplantation|February 1, 1995
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or bothI Langenmayer, C Weaver, C D Buckner, et al.
Blood|December 1, 1992
The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboonsR G Andrews, W I Bensinger, G H Knitter, et al.
Bone Marrow Transplantation|June 2, 2009
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilizationM J Dugan, R T Maziarz, W I Bensinger, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Bone Marrow Transplantation|April 25, 2001
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and olderA K Gopal, T A Gooley, J B Golden, et al.
Bone Marrow Transplantation|June 1, 1995
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantationT Demirer, T Gooley, C D Buckner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapyT Demirer, C H Weaver, C D Buckner, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|September 1, 1996
Syngeneic marrow transplantation in patients with multiple myelomaW I Bensinger, T Demirer, C D Buckner, et al.
Leukemia|March 2, 2012
Evaluating surface erythropoietin receptor in multiple myelomaC P Miller, K Rattray, Y Zhang, et al.
Bone Marrow Transplantation|November 1, 1994
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignanciesC H Weaver, W I Bensinger, F R Appelbaum, et al.
Bone Marrow Transplantation|February 1, 1995
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or bothI Langenmayer, C Weaver, C D Buckner, et al.
Blood|December 1, 1992
The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboonsR G Andrews, W I Bensinger, G H Knitter, et al.
Bone Marrow Transplantation|June 2, 2009
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilizationM J Dugan, R T Maziarz, W I Bensinger, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Bone Marrow Transplantation|April 25, 2001
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and olderA K Gopal, T A Gooley, J B Golden, et al.
Bone Marrow Transplantation|June 1, 1995
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantationT Demirer, T Gooley, C D Buckner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapyT Demirer, C H Weaver, C D Buckner, et al.
Pageof 16